Miaoling Li

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Nlrp Inflammasome

Epithelial Mesenchymal Transition

Left Ventricular

Top Venues

Oxidative medicine and cellular longevity

Journal of cardiovascular translational research

This page only lists publications with an associated author ORCID identifier.

Publications

Chendong Peng, Jie Yan, Yu'ang Jiang, Lin Wu, Miaoling Li, Xinrong Fan
Exploring Cutting-Edge Approaches to Potentiate Mesenchymal Stem Cell and Exosome Therapy for Myocardial Infarction. Journal of cardiovascular translational research (2023)
Juan Zhang, Dan Luo, Fang Li, Zhiyi Li, Xiaoli Gao, Jie Qiao, Lin Wu, Miaoling Li
Ginsenoside Rg3 Alleviates Antithyroid Cancer Drug Vandetanib-Induced QT Interval Prolongation. Oxidative medicine and cellular longevity 2021 (2021)
Junteng Zhou, Geer Tian, Yue Quan, Junli Li, Xiaojiao Wang, Wenchao Wu, Miaoling Li, Xiaojing Liu
Inhibition of P2X7 Purinergic Receptor Ameliorates Cardiac Fibrosis by Suppressing NLRP3/IL-1β Pathway. Oxidative medicine and cellular longevity 2020 (2020)
Rongfang He, Juan Zhang, Dan Luo, Yiyan Yu, Tangting Chen, Yan Yang, Fengxu Yu, Miaoling Li
Upregulation of Transient Receptor Potential Canonical Type 3 Channel via AT1R/TGF-β1/Smad2/3 Induces Atrial Fibrosis in Aging and Spontaneously Hypertensive Rats. Oxidative medicine and cellular longevity 2019 (2019)